| Bioactivity | DBCO-PEG3-Glu-Val-Cit-PABC-MMAE is a drug-linker conjugate for ADC. DBCO-PEG3-Glu-Val-Cit-PABC-MMAE contains a potent tubulin inhibitor Monomethyl auristatin E (MMAE, HY-15162) and can be used for synthesis of dual-drug ADC[1]. |
| CAS | 2861998-23-2 |
| Formula | C90H129N13O21 |
| Molar Mass | 1729.06 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yamazaki CM, et al. Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nat Commun. 2021 Jun 10;12(1):3528. |
DBCO-PEG3-Glu-Val-Cit-PABC-MMAE
CAS: 2861998-23-2 F: C90H129N13O21 W: 1729.06
DBCO-PEG3-Glu-Val-Cit-PABC-MMAE is a drug-linker conjugate for ADC. DBCO-PEG3-Glu-Val-Cit-PABC-MMAE contains a potent tu
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.